I received this announcement in my email this morning and wanted to share it with you. If you or anyone you know can help with this study it would be a terrific opportunity to allow for discovery of the effects caused by these medications.
If you are a pregnant woman between the ages of 18 and 45 and currently treated with one or more of the following atypical antipsychotics:
- Abilify (aripiprazole)
- Clozaril (clozapine)
- Geodon (ziprasidone)
- Invega (paliperidone)
- Risperdal (risperidone)
- Seroquel (quetiapine)
- Zyprexa (olanzapine)
Register now by calling 1-866-961-2388 and help us learn more about the safety of these medicines in pregnancy.
This study will involve 3 brief phone interviews over approximately 8-months.
The National Pregnancy Registry for Atypical Antipsychotics was developed to obtain information about the safety of atypical (second generation) antipsychotic medications when used during pregnancy. The primary goal of this Registry is to determine the frequency of major malformations seen after use of atypical antipsychotics during pregnancy compared to what is seen among women who do not take such medications during pregnancy.
For more information about the Registry, please call 1-866-961-2388
Copyright 2008 – Massachusetts General Hospital